Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Conditions
Adenovirus · Primary Immune Deficiency Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital Los Angeles, Los Angeles, California, United States
University of California San Francisco, San Francisco, California, United States
Children's Hospital of Colorado, Aurora, Colorado, United States
Contact: Study coordinator (Michael Verneris, MD) · Michael.Verneris@childrenscolorado.org · 720-777-1234University of Colorado Denver, Aurora, Colorado, United States
Indiana University, Indianapolis, Indiana, United States
Johns Hopkins, Baltimore, Maryland, United States
Contact: Study coordinator (Kenneth Cooke, MD)Washington University, St Louis, Missouri, United States
Nationwide Children's Hosptial, Columbus, Ohio, United States
Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania, United States
Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Study leads
Mitchell Cairo, MD
Principal Investigator
New York Medical College